Using glucocorticoids, rituzimab, or certain immunosuppressants to treat connective tissue diseases is associated with greater risks for severe COVID-19-related outcomes.

Using glucocorticoids, rituzimab, or certain immunosuppressants to treat connective tissue diseases is associated with greater risks for severe COVID-19-related outcomes.

Patients with connective tissue diseases who experienced ... (1.8%), primary Sjögren syndrome (1.1%), and mixed connective tissue disease (MCTD; 0.04%). Patients with MCTDs were excluded from ...

Mixed connective tissue disease (MCTD) is a complex overlap disease with features of different autoimmune connective tissue diseases (CTDs) namely systemic sclerosis, poly/dermatomyositis and systemic ...

Psoriatic Arthritis vs. Mixed Connective Tissue Disease: What Are the Differences? Psoriatic Arthritis vs. Multiple Sclerosis: What Are the Differences? Psoriatic Arthritis vs. Lupus: What Are the ...

Rare and complex connective tissue diseases comprise a large number of diseases and syndromes including hereditary (Ehlers-Danlos syndromes and related disorders), rare systemic immune-mediated ...